Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer.
Ontology highlight
ABSTRACT: Disparities in estrogen receptor (ER), progesterone receptor, human epidermal growth factor receptor 2 (HER2), and Ki67 proliferation indices facilitate the categorization of breast cancer into four principal subtypes: luminal A, luminal B, HER2-positive, and triple-negative breast cancer (TNBC). Preclinical studies investigating the therapeutic potential of histaminergic system targeting in breast cancer have shown promising results. This study aimed to assess the expression profiles of messenger ribonucleic acid (mRNA) and micro RNA (miRNA) related to the histaminergic system in five subtypes of breast cancer among Polish women. Patients with five breast cancer subtypes were included in the study: luminal A (n = 130), luminal B (n = 196, including HER2-, n =100; HER2+, n= 96), HER2+ (n =
SUBMITTER: Sirek T
PROVIDER: S-EPMC11390352 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA